Comparing 1 hypotheses side-by-side
## Molecular Mechanism and Rationale APOE4-Specific Lipidation Enhancement Therapy targets the fundamental molecular deficiency that distinguishes the APOE4 isoform from its neuroprotective counterparts, APOE2 and APOE3. The apolipoprotein E (APOE) protein exists in three major human isoforms, differing by only two amino acids: APOE2 (Cys112, Cys158), APOE3 (Cys112, Arg158), and APOE4 (Arg112, Arg158). These seemingly minor variations have profound structural and functional consequences, partic
| Dimension | APOE4-Specific Lipidation Enha |
|---|---|
| Mechanistic | 0.000 |
| Evidence | 0.000 |
| Novelty | 0.000 |
| Feasibility | 0.000 |
| Impact | 0.000 |
| Druggability | 0.000 |
| Safety | 0.000 |
| Competition | 0.000 |
| Data | 0.000 |
| Reproducible | 0.000 |